Abstract
We report the development of macrocyclic melanocortin derivatives of MT-II and SHU-9119, achieved by modifying the cycle dimension and incorporating constrained amino acids in ring-closing. This study culminated in the discovery of novel agonists/antagonists with an unprecedented activity profile by adding pieces to the puzzle of the melanocortin receptor selectivity. Finally, the resulting 19- and 20-membered rings represent a suitable frame for the design of further therapeutic ligands as selective modulators of the melanocortin system.
Original language | English (US) |
---|---|
Pages (from-to) | 4263-4269 |
Number of pages | 7 |
Journal | Journal of Medicinal Chemistry |
Volume | 61 |
Issue number | 9 |
DOIs | |
State | Published - May 10 2018 |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery
Fingerprint
Dive into the research topics of 'Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors'. Together they form a unique fingerprint.Datasets
-
NMR ensemble of Macrocyclic Peptidomimetic Containing Constrained a,a-dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors
Merlino, F. (Contributor), Zhou, Y. (Contributor), Cai, M. (Contributor), Carotenuto, A. (Contributor), Yousif, A. M. (Contributor), Brancaccio, D. (Contributor), Di Maro, S. (Contributor), Zappavigna, S. (Contributor), Limatola, A. (Contributor), Novellino, E. (Contributor), Grieco, P. (Contributor) & Hruby, V. J. (Contributor), Protein Data Bank (PDB), Apr 25 2018
DOI: 10.2210/pdb6FCE/pdb, https://www.wwpdb.org/pdb?id=pdb_00006fce
Dataset